Delivery Order SPE2DB22D2007-SPE2DB24FJ2WG

Award Date 5/28/24
Potential Completion Date 6/18/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product TAGRISSO 40 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $21,016.64 and a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the company...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceuticals, including the drug TAGRISSO 40 MG TABLET 30S. The $21,016.64 contract is a firm fixed price delivery order awarded on June 7, 2024 with an ultimate completion date of July 1, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition services to the U.S. Armed Forces. Amerisourcebergen also...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $90,841.23 in firm fixed-price delivery orders for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of August 4, 2022 and was awarded on July 14, 2022. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $10,538.79 Firm Fixed Price Delivery Order for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,016.64 firm fixed price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024 and was awarded on July 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The $10,247.06 firm-fixed-price delivery order has a completion date of June 7, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAGRISSO 80 MG TABLET 30S. The contract has a ceiling value of $10,662.57 and runs through April 9, 2025. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order contract type. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $31,524.93, is a Firm Fixed Price Delivery Order for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $21,077.60 to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,538.79 firm fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2WG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription drug TAGRISSO 80 MG TABLET 30S to the Defense Logistics Agency (DLA). The $21,077.60 firm fixed price delivery order has an ultimate completion date of June 18, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. This order is likely placed against that larger IDC vehicle. There is no set-aside designation for this specific contract award.

Generated 8/27/24, 10:17 AM